Lipopolysaccharide augments the uptake of oxidized LDL by up-regulating lectin-like oxidized LDL receptor-1 in macrophages

详细信息    查看全文

• 作者：Ekhtear Hossain (1)
  Akinobu Ota (1) (3)
  Sivasundaram Karnan (1)
  Miyuki Takahashi (1) (2)
  Shahnewaj B. Mannan (1)
  Hiroyuki Konishi (1)
  Yoshitaka Hosokawa (1)
  
  1. Department of Biochemistry ; Aichi Medical University School of Medicine ; Nagakute ; Aichi ; Japan
  3. Department of Biochemistry ; Aichi Medical University School of Medicine ; 1-1 Yazakokarimata ; Building #2 ; Room 362 ; Nagakute ; Aichi ; 480-1195 ; Japan
  2. Division of Hematology ; Department of Internal Medicine ; Aichi Medical University School of Medicine ; Nagakute ; Aichi ; Japan
  
• 关键词：LPS ; LOX ; 1 ; Atherosclerosis ; Erk1/2 ; Molecular biology
• 刊名：Molecular and Cellular Biochemistry
• 出版年：2015
• 出版时间：February 2015
• 年：2015
• 卷：400
• 期：1-2
• 页码：29-40
• 全文大小：3,021 KB
• 参考文献：1. Taghavie-Moghadam PL, Butcher MJ, Galkina EV (2014) The dynamic lives of macrophage and dendritic cell subsets in atherosclerosis. Ann N Y Acad Sci 19:19鈥?7 CrossRef
  2. Tabas I (2010) Macrophage death and defective inflammation resolution in atherosclerosis. Nat Rev Immunol 10:36鈥?6 CrossRef
  3. Libby P, Lichtman AH, Hansson GK (2013) Immune effector mechanisms implicated in atherosclerosis: from mice to humans. Immunity 38:1092鈥?104 16/j.immuni.2013.06.009" target="_blank" title="It opens in new window">CrossRef
  4. Libby P, Ridker PM, Hansson GK (2011) Progress and challenges in translating the biology of atherosclerosis. Nature 473:317鈥?25 CrossRef
  5. Goyal T, Mitr S, Khaidakov M, Wang X, Singla S, Ding Z, Liu S, Mehta JL (2012) Current concepts of the role of oxidized LDL receptors in atherosclerosis. Curr Atheroscler Rep 14:150鈥?59 CrossRef
  6. Mart铆n-Fuentes P, Civeira F, Recalde D, Garc铆a-Ot铆n AL, Jarauta E, Marzo I, Cenarro A (2007) Individual variation of scavenger receptor expression in human macrophages with oxidized low-density lipoprotein is associated with a differential inflammatory response. J Immunol 179:3242鈥?248 CrossRef
  7. Sawamura T, Kume N, Aoyama T, Moriwaki H, Hoshikawa H, Aiba Y, Tanaka T, Miwa S, Katsura Y, Kita T, Masaki T (1997) An endothelial receptor for oxidized low-density lipoprotein. Nature 386:73鈥?7 CrossRef
  8. Mitra S, Goyal T, Mehta JL (2011) Oxidized LDL, LOX-1 and atherosclerosis. Cardiovasc Drugs Ther 5:419鈥?29 CrossRef
  9. Kataoka H, Kume N, Miyamoto S, Minami M, Moriwaki H, Murase T, Sawamura T, Masaki T, Hashimoto T, Kita T (1999) Expression of lectin-like oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions. Circulation 99:3110鈥?117 161/01.CIR.99.24.3110" target="_blank" title="It opens in new window">CrossRef
  10. Inoue K, Arai Y, Kurihara H, Kita T, Sawamura T (2005) Overexpression of lectin-like oxidized low-density lipoprotein receptor-1 induces intramyocardial vasculopathy in apolipoprotein E-null mice. Circ Res 97:176鈥?84 161/01.RES.0000174286.73200.d4" target="_blank" title="It opens in new window">CrossRef
  11. Ding Z, Mizeracki AM, Hu C, Mehta JL (2013) LOX-1 deletion and macrophage trafficking in atherosclerosis. Biochem Biophys Res Commun 440:210鈥?14 16/j.bbrc.2013.09.020" target="_blank" title="It opens in new window">CrossRef
  12. Taront S, Dieudonn茅 A, Blanchard S, Jeannin P, Lassalle P, Delneste Y, Gosset P (2009) Implication of scavenger receptors in the interactions between diesel exhaust particles and immature or mature dendritic cells. Part Fibre Toxicol 6:9 CrossRef
  13. Funk JL, Feingold KR, Moser AH, Grunfeld C (1993) Lipopolysaccharide stimulation of RAW 264.7 macrophages induces lipid accumulation and foam cell formation. Atherosclerosis 98:67鈥?2 16/0021-9150(93)90224-I" target="_blank" title="It opens in new window">CrossRef
  14. El Fiky A, Perreault R, McGinnis GJ, Rabin RL (2013) Attenuated expression of interferon-尾 and interferon-位1 by human alternatively activated macrophages. Hum Immunol 74:1524鈥?530 16/j.humimm.2013.08.267" target="_blank" title="It opens in new window">CrossRef
  15. Komura T, Sakai Y, Honda M, Takamura T, Wada T, Kaneko S (2013) ER stress induced impaired TLR signaling and macrophage differentiation of human monocytes. Cell Immunol 282:44鈥?2 16/j.cellimm.2013.04.006" target="_blank" title="It opens in new window">CrossRef
  16. Takahashi M, Ota A, Karnan S, Hossain E, Konishi Y, Damdindorj L, Konishi H, Yokochi T, Nitta M, Hosokawa Y (2013) Arsenic trioxide prevents nitric oxide production in lipopolysaccharide-stimulated RAW264.7 by inhibiting a TRIF-dependent pathway. Cancer Sci 104:165鈥?70 CrossRef
  17. Hossain E, Ota A, Takahashi M, Karnan S, Damdindorj L, Konishi Y, Konishi H, Hosokawa Y (2013) Arsenic upregulates the expression of angiotensin II Type I receptor in mouse aortic endothelial cells. Toxicol Lett 220:70鈥?5 16/j.toxlet.2013.04.006" target="_blank" title="It opens in new window">CrossRef
  18. Hossain E, Ota A, Karnan S, Damdindorj L, Takahashi M, Konishi Y, Konishi H, Hosokawa Y (2013) Arsenic augments the uptake of oxidized LDL by upregulating the expression of lectin-like oxidized LDL receptor in mouse aortic endothelial cells. Toxicol Appl Pharmacol 273:651鈥?58 16/j.taap.2013.10.012" target="_blank" title="It opens in new window">CrossRef
  19. Zernecke A, Weber C (2014) Chemokines in atherosclerosis: proceedings resumed. Arterioscler Thromb Vasc Biol 34:742鈥?50 161/ATVBAHA.113.301655" target="_blank" title="It opens in new window">CrossRef
  20. Chen J, Liu Y, Liu H, Hermonat PL, Mehta JL (2006) Molecular dissection of angiotensin II-activated human LOX-1 promoter. Arterioscler Thromb Vasc Biol 26:1163鈥?168 161/01.ATV.0000209998.73303.b5" target="_blank" title="It opens in new window">CrossRef
  21. Ueno T, Fukuda N, Tsunemi A, Yao EH, Matsuda H, Tahira K, Matsumoto T, Matsumoto K, Matsumoto Y, Nagase H, Sugiyama H, Sawamura T (2009) A novel gene silencer, pyrrole-imidazole polyamide targeting human lectin-like oxidized low-density lipoprotein receptor-1 gene improves endothelial cell function. J Hypertens 27:508鈥?16 CrossRef
  22. Chen M, Masaki T, Sawamura T (2002) LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis. Pharmacol Ther 95:89鈥?00 16/S0163-7258(02)00236-X" target="_blank" title="It opens in new window">CrossRef
  23. Hu C, Dandapat A, Sun L, Chen J, Marwali MR, Romeo F, Sawamura T, Mehta JL (2008) LOX-1 deletion decreases collagen accumulation in atherosclerotic plaque in low-density lipoprotein receptor knockout mice fed a high-cholesterol diet. Cardiovasc Res 79:287鈥?93 CrossRef
  24. Kume N, Murase T, Moriwaki, Aoyama T, Sawamura T, Masaki T, Kita T (1998) Inducible expression of lectin-like oxidized LDL receptor-1 in vascular endothelial cells. Circ Res 83:322鈥?27 161/01.RES.83.3.322" target="_blank" title="It opens in new window">CrossRef
  25. Nagase M, Abe J, Takahashi K, Ando J, Hirose S, Fujita T (1998) Genomic organization and regulation of expression of the lectin-like oxidized low-density lipoprotein receptor (LOX-1) gene. J Biol Chem 273:33702鈥?3707 CrossRef
  26. Li D, Mehta JL (2000) Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells: evidence from use of antisense LOX-1 mRNA and chemical inhibitors. Arterioscler Thromb Vasc Biol 20:1116鈥?122 161/01.ATV.20.4.1116" target="_blank" title="It opens in new window">CrossRef
  27. Murase T, Kume N, Korenaga R, Ando J, Sawamura T, Masaki T, Kita T (1998) Fluid shear stress transcriptionally induces lectin-like oxidized LDL receptor-1 in vascular endothelial cells. Circ Res 83:328鈥?33 161/01.RES.83.3.328" target="_blank" title="It opens in new window">CrossRef
  28. Schaeffer DF, Riazy M, Parhar KS, Chen JH, Duronio V, Sawamura T, Steinbrecher UP (2009) LOX-1 augments oxLDL uptake by lysoPC-stimulated murine macrophages but is not required for oxLDL clearance from plasma. J Lipid Res 50:1676鈥?684 167-JLR200" target="_blank" title="It opens in new window">CrossRef
  29. Hermonat PL, Zhu H, Cao M, Mehta JL (2011) LOX-1 transcription. Cardiovasc Drugs Ther 25:393鈥?00 CrossRef
  30. Zhao W, Ma G, Chen X (2014) Lipopolysaccharide induced LOX-1 expression via TLR4/MyD88/ROS activated p38MAPK-NF-魏B pathway. Vascul Pharmacol S1537鈥?891(14):00128-1. doi:10.1016/j.vph.2014.06.008
  31. Fitzgerald ML, Moore KJ, Freeman MW, Reed GL (2000) Lipopolysaccharide induces scavenger receptor A expression in mouse macrophages: a divergent response relative to human THP-1 monocyte/macrophages. J Immunol 164:2692鈥?700 164.5.2692" target="_blank" title="It opens in new window">CrossRef
  32. Yesner LM, Huh HY, Pearce SF, Silverstein RL (1996) Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediators. Arterioscler Thromb Vasc Biol 16:1019鈥?025 161/01.ATV.16.8.1019" target="_blank" title="It opens in new window">CrossRef
  33. Kataoka H, Kume N, Miyamoto S, Minami M, Moriwaki H, Murase T, Sawamura T, Masaki T, Hashimoto N, Kita T (1999) Expression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions. Circulation 99:3110鈥?117 161/01.CIR.99.24.3110" target="_blank" title="It opens in new window">CrossRef
  
• 刊物类别：Biomedical and Life Sciences
• 刊物主题：Life Sciences
  Biochemistry
  Medical Biochemistry
  Oncology
  Cardiology
  
• 出版者：Springer Netherlands
• ISSN：1573-4919

文摘

There is a growing body of evidence supporting an intimate association of immune activation with the pathogenesis of cardiovascular diseases, including atherosclerosis. Uptake of oxidized low-density lipoprotein (oxLDL) through scavenging receptors promotes the formation of mature lipid-laden macrophages, which subsequently leads to exacerbation of regional inflammation and atherosclerotic plaque formation. In this study, we first examined changes in the mRNA level of the lectin-like oxLDL receptor-1 (LOX-1) in the mouse macrophage cell line RAW264.7 and the human PMA-induced macrophage cell line THP-1 after LPS stimulation. LPS significantly up-regulated LOX-1 mRNA in RAW264.7 cells; LOX-1 cell-surface protein expression was also increased. Flow cytometry and fluorescence microscopy analyses showed that cellular uptake of fluorescence (Dil)-labeled oxLDL was significantly augmented with LPS stimulation. The augmented uptake of Dil-oxLDL was almost completely abrogated by treatment with an anti-LOX-1 antibody. Of note, knockdown of Erk1/2 resulted in a significant reduction of LPS-induced LOX-1 up-regulation. Treatment with U0126, a specific inhibitor of MEK, significantly suppressed LPS-induced expression of LOX-1 at both the mRNA and protein levels. Furthermore, LOX-1 promoter activity was significantly augmented by LPS stimulation; this augmentation was prevented by U0126 treatment. Similar results were also observed in human PMA-induced THP-1 macrophages. Taken together, our results indicate that LPS up-regulates LOX-1, at least in part through activation of the Erk1/2 signaling pathway, followed by augmented cellular oxLDL uptake, thus highlighting a critical role of TLR4-mediated aberrant LOX-1 signaling in the pathogenesis of atherosclerosis.